Total brain APP and A oligomer levels are reduced in Liraglutide-treated AD mice (147, 158160), and intervention with liraglutide can prevent tau hyperphosphorylation (161164)
Our medical team focuses on what works for you
Siegel EG, Gallwitz B, Scharf G, Mentlein R, Morys-Wortmann C, Folsch UR, Schrezenmeir J, Drescher K, Schmidt WE (1999) Biological activity of GLP-1-analogues with N-terminal modifications
Ozempic Babies/Ozempic Pregnancy Concerns are also emerging about Ozempic use during pregnancy, as some reports suggest it may pose risks to unborn children when taken before or during pregnancy
Veterans Affairs databases found that GLP-1RA use was associated with reduced risks of major adverse cardiovascular events (MACE), stroke, heart failure, cardiac arrest, and thromboembolic disorders
Therapeutic strategies and biomarkers to modulate PARP activity for targeted cancer therapy